SEC Form 4 · accession 0001209191-18-038555
Spring Bank Pharmaceuticals, Inc. · SBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kurt M Eichler
Director
Period of report
Jun 18, 2018
Accepted (ET)
Jun 19, 2018 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001566373
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $13.99 | Jun 18, 2018 | A | 5,500 | A | — | Jun 17, 2028 | Common Stock | 5,500 | 5,500 | D |
Explanation of responses
- F1Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on June 18, 2018, the date of the Issuer's 2018 Annual Meeting of Stockholder, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date.